Click below to see our affiliate company
/ MJD Supplements/Shop Now
COVID-19 AND PROSTATE CANCER WHAT YOU SHOULD KNOW We will keep you updated on the latest information as we continue to monitor the coronavirus pandemic as it affects our patients.
CLICK HERE TO LEARN MORE
Patients of similar prognosis. Patients can be grouped into Low, Intermediate and High risk groups based on PSA, Gleason score and stage. Risk group classification can be helpful in assessing treatment options and comparing different treatments.